Compare Dr. Reddys with VENUS REMEDIES - Equitymaster

Helping You Build Wealth With Honest Research
Since 1996. Try Now

  • MyStocks

MEMBER'S LOGINX

     
Login Failure
   
     
   
     
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

DR. REDDYS LAB vs VENUS REMEDIES - Comparison Results

DR. REDDYS LAB     Change

Dr. Reddy's is a leading pharmaceutical company in the country with presence across the pharmaceutical value chain - basic research, finished dosages, generics, bulk actives, and biotechnology. The company's business is mainly organized into Global g... More

DO YOU LIKE THESE REPORTS? TELL US!

Current Valuations

    DR. REDDYS LAB VENUS REMEDIES DR. REDDYS LAB/
VENUS REMEDIES
 
P/E (TTM) x 34.3 -9.7 - View Chart
P/BV x 4.7 0.6 723.9% View Chart
Dividend Yield % 0.6 0.0 -  

Financials

 DR. REDDYS LAB   VENUS REMEDIES
EQUITY SHARE DATA
    DR. REDDYS LAB
Mar-20
VENUS REMEDIES
Mar-18
DR. REDDYS LAB/
VENUS REMEDIES
5-Yr Chart
Click to enlarge
High Rs3,363126 2,671.2%   
Low Rs2,35261 3,849.4%   
Sales per share (Unadj.) Rs1,054.2301.8 349.3%  
Earnings per share (Unadj.) Rs121.9-24.9 -490.2%  
Cash flow per share (Unadj.) Rs190.22.5 7,475.3%  
Dividends per share (Unadj.) Rs25.000-  
Dividend yield (eoy) %0.90-  
Book value per share (Unadj.) Rs938.7293.3 320.1%  
Shares outstanding (eoy) m166.1712.34 1,346.6%   
Bonus/Rights/Conversions ESOP--  
Price / Sales ratio x2.70.3 874.9%   
Avg P/E ratio x23.4-3.8 -623.4%  
P/CF ratio (eoy) x15.036.7 40.9%  
Price / Book Value ratio x3.00.3 954.8%  
Dividend payout %20.50-   
Avg Mkt Cap Rs m474,8311,154 41,154.0%   
No. of employees `00021.70.9 2,340.5%   
Total wages/salary Rs m33,802393 8,598.8%   
Avg. sales/employee Rs Th8,091.04,026.1 201.0%   
Avg. wages/employee Rs Th1,561.3425.0 367.4%   
Avg. net profit/employee Rs Th935.8-331.8 -282.1%   
INCOME DATA
Net Sales Rs m175,1703,724 4,703.7%  
Other income Rs m6,20623 27,582.2%   
Total revenues Rs m181,3763,747 4,841.1%   
Gross profit Rs m24,421395 6,185.7%  
Depreciation Rs m11,348338 3,354.4%   
Interest Rs m983354 277.4%   
Profit before tax Rs m18,296-275 -6,645.8%   
Minority Interest Rs m00-   
Prior Period Items Rs m5610-   
Extraordinary Inc (Exp) Rs m00-   
Tax Rs m-1,40332 -4,439.9%   
Profit after tax Rs m20,260-307 -6,601.5%  
Gross profit margin %13.910.6 131.5%  
Effective tax rate %-7.7-11.5 66.8%   
Net profit margin %11.6-8.2 -140.3%  
BALANCE SHEET DATA
Current assets Rs m125,9912,638 4,776.6%   
Current liabilities Rs m72,1412,305 3,130.2%   
Net working cap to sales %30.78.9 343.8%  
Current ratio x1.71.1 152.6%  
Inventory Days Days73135 54.0%  
Debtors Days Days10546 226.1%  
Net fixed assets Rs m83,8544,871 1,721.6%   
Share capital Rs m831123 673.4%   
"Free" reserves Rs m155,1573,496 4,438.5%   
Net worth Rs m155,9883,619 4,310.1%   
Long term debt Rs m1,3041,374 94.9%   
Total assets Rs m232,2537,509 3,093.2%  
Interest coverage x19.60.2 8,795.8%   
Debt to equity ratio x00.4 2.2%  
Sales to assets ratio x0.80.5 152.1%   
Return on assets %9.10.6 1,448.9%  
Return on equity %13.0-8.5 -153.2%  
Return on capital %12.61.6 797.3%  
Exports to sales %00-   
Imports to sales %013.9 0.0%   
Exports (fob) Rs mNANA-   
Imports (cif) Rs mNA517 0.0%   
Fx inflow Rs m84,1930-   
Fx outflow Rs m39,616517 7,670.1%   
Net fx Rs m44,577-517 -8,630.6%   
CASH FLOW
From Operations Rs m29,841514 5,801.1%  
From Investments Rs m-4,923-123 3,999.2%  
From Financial Activity Rs m-25,159-387 6,499.4%  
Net Cashflow Rs m-2664 -6,333.3%  

Share Holding

Indian Promoters % 25.5 32.9 77.6%  
Foreign collaborators % 0.0 0.0 -  
Indian inst/Mut Fund % 5.4 0.2 3,000.0%  
FIIs % 35.3 0.6 6,086.2%  
ADR/GDR % 18.5 0.0 -  
Free float % 15.3 66.4 23.0%  
Shareholders   75,885 20,121 377.1%  
Pledged promoter(s) holding % 0.0 36.4 -  
NM: Not Meaningful
Source: Company Annual Reports, Regulatory Filings, Equitymaster

Compare DR. REDDYS LAB With:   ASTRAZENECA PHARMA  ALEMBIC PHARMA  CADILA HEALTHCARE  NOVARTIS  DR. DATSONS LABS  

Compare DR. REDDYS LAB With:   ADCOCK INGRAM (S. Africa)  MYLAN (US)  ACTAVIS (US)  TEVA PHARMA (Israel)  



Today's Market

Bloodbath on Dalal Street: 6 Reasons Why Sensex Nosedived 1,939 Points Today(Closing)

Indian share markets witnessed a sharp sell-off today and ended deep in the red.

Related Views on News

VENUS REMEDIES Announces Quarterly Results (4QFY19); Net Profit Down 11.1% (Quarterly Result Update)

Jun 12, 2019 | Updated on Jun 12, 2019

For the quarter ended March 2019, VENUS REMEDIES has posted a net profit of Rs 104 m (down 11.1% YoY). Sales on the other hand came in at Rs 864 m (down 7.3% YoY). Read on for a complete analysis of VENUS REMEDIES's quarterly results.

VENUS REMEDIES Announces Quarterly Results (4QFY19); Net Profit Down 11.1% (Quarterly Result Update)

Jun 12, 2019 | Updated on Jun 12, 2019

For the quarter ended March 2019, VENUS REMEDIES has posted a net profit of Rs 104 m (down 11.1% YoY). Sales on the other hand came in at Rs 864 m (down 7.3% YoY). Read on for a complete analysis of VENUS REMEDIES's quarterly results.

More Views on News

Most Popular

It's the Beginning of a New Bull Phase in Smallcaps(Profit Hunter)

Feb 24, 2021

Last time the smallcap index crossed 19k a big correction followed. Here's what makes it different this time.

Intraday Trading for a Living(Fast Profits Daily)

Feb 15, 2021

In this video, I'll cover your queries on intraday trading and also share my view on how to decide stop losses and target prices.

Top 5 Stocks Mutual Funds Bought and Sold in January 2021(Sector Info)

Feb 16, 2021

A look at what India's top equity mutual funds bought and sold in January 2021.

I Would Recommend this Small-cap Stock Over Tesla(Profit Hunter)

Feb 16, 2021

Do you enjoy reading Tesla and Bitcoin stories? Here's a not so famous small-cap stock to profit from the rise of EVs.

More

India's #1 Trader
Reveals His Secrets

Secret To Increasing Your Trading Profits Today
Get this Special Report,
The Secret to Increasing Your Trading Profits Today, Now!
We will never sell or rent your email id.
Please read our Terms

DR. REDDYS LAB SHARE PRICE


Feb 26, 2021 (Close)

TRACK DR. REDDYS LAB

  • Track your investment in DR. REDDYS LAB with Equitymaster's Portfolio Tracker. Set live price alerts, get research alerts and more. Get access now...
  • Add To MyStocks

DR. REDDYS LAB 5-YR ANALYSIS

COMPARE DR. REDDYS LAB WITH

MARKET STATS